113 related articles for article (PubMed ID: 38394609)
1. Interferon-Gamma Responses to Chlamydia trachomatis Vaccine Candidate Proteins in Chlamydia-Infected Women with Different Chlamydia Outcomes.
Dziadula J; Sabbaj S; Gupta K; Cutter G; Yu H; Brunham RC; Geisler WM
J Infect Dis; 2024 Feb; ():. PubMed ID: 38394609
[TBL] [Abstract][Full Text] [Related]
2. An Adaptive
Bakshi RK; Gupta K; Jordan SJ; Chi X; Lensing SY; Press CG; Geisler WM
Front Immunol; 2018; 9():1981. PubMed ID: 30245688
[No Abstract] [Full Text] [Related]
3. Antibody responses to
Yu H; Geisler WM; Dai C; Gupta K; Cutter G; Brunham RC
Front Cell Infect Microbiol; 2024; 14():1342621. PubMed ID: 38371301
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to Variable Domain 4 Linear Epitopes of the
Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
[No Abstract] [Full Text] [Related]
5. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Vaccine; 2014 Aug; 32(36):4672-80. PubMed ID: 24992718
[TBL] [Abstract][Full Text] [Related]
7. High expression of IDO1 and TGF-β1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-γ response.
Ziklo N; Huston WM; Taing K; Timms P
BMC Infect Dis; 2019 Mar; 19(1):218. PubMed ID: 30832593
[TBL] [Abstract][Full Text] [Related]
8. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.
Tu J; Hou B; Wang B; Lin X; Gong W; Dong H; Zhu S; Chen S; Xue X; Zhao KN; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2014 May; 46(5):401-8. PubMed ID: 24681882
[TBL] [Abstract][Full Text] [Related]
9. The Predominant CD4
Jordan SJ; Gupta K; Ogendi BMO; Bakshi RK; Kapil R; Press CG; Sabbaj S; Lee JY; Geisler WM
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28100498
[No Abstract] [Full Text] [Related]
10. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
11. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.
Vasilevsky S; Stojanov M; Greub G; Baud D
Virulence; 2016; 7(1):11-22. PubMed ID: 26580416
[TBL] [Abstract][Full Text] [Related]
12. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
Igietseme JU; Murdin A
Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
[TBL] [Abstract][Full Text] [Related]
13. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance.
Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P
PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080
[TBL] [Abstract][Full Text] [Related]
14. Gamma Interferon Is Required for
Helble JD; Gonzalez RJ; von Andrian UH; Starnbach MN
mBio; 2020 Mar; 11(2):. PubMed ID: 32184237
[TBL] [Abstract][Full Text] [Related]
15. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC
Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151
[TBL] [Abstract][Full Text] [Related]
17. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis.
Williams DM; Grubbs BG; Pack E; Kelly K; Rank RG
Infect Immun; 1997 Jul; 65(7):2876-82. PubMed ID: 9199462
[TBL] [Abstract][Full Text] [Related]
19. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
[TBL] [Abstract][Full Text] [Related]
20. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.
Dong-Ji Z; Yang X; Shen C; Lu H; Murdin A; Brunham RC
Infect Immun; 2000 Jun; 68(6):3074-8. PubMed ID: 10816446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
